bioRxivMolecular BiologyPreprint
Hepatic retromer is essential for systemic cholesterol homeostasis by regulating lysosomal cholesterol metabolism
Dyonne Y. VosiD, Markus Gregorio Barbosa, Andries HeidaiD, Amandine CaillaudiD, Joël J. TissinkiD, Mirjam H. KosteriD, Marieke SmitiD, Nicolette HuijkmaniD, Niels KloosterhuisiD, Aurore GirardeauiD, Zoé Begué-RacapéiD, Vincent W. BloksiD, Rick Havinga, Marceline Manka Fuh, Fulvio ReggioriiD, Muriel C. MariiD, Ludger SchejaiD, Jöerg HeereniD, Folkert KuipersiD, Jan Freark de BoeriD, Antoine RimbertiD, Justina Clarinda WoltersiD, Jan Albert KuivenhoveniD, Cristy R.C. VerzijliD, Bart van de SluisiD
Abstract
BackgroundDisturbed hepatic cholesterol homeostasis is associated with multiple diseases, including atherosclerotic cardiovascular disease and metabolic dysfunction- associated steatotic liver disease. The endo-lysosomal system is essential for cholesterol uptake and intracellular distribution, yet the mechanisms governing these processes remain incompletely understood. Here, we investigated the impact of hepatic VPS35, a subunit of the endosomal sorting complex retromer, on hepatocellular and whole-body cholesterol homeostasis. MethodsWe generated a liver-specific Vps35 knockout mouse model (Vps35HepKO) and applied biochemical analyses, proteomics, and stable-isotope-labeled tracers to quantify critical processes of cholesterol metabolism. Human iPSC-derived liver organoids and CRISPR technology were used to translate our findings to humans. Mechanistic studies were performed in precision-cut liver slices from WT and Vps35HepKO mice. ResultsHepatic VPS35 deficiency led to an increase in endo-lysosomal degradative compartments and a marked reduction in specific lysosomal proteins, including lysosomal acid lipase (LAL), Scavenger Receptor Class B Member 2 (SCARB2), and Niemann-Pick type C1 (NPC1). Using pathway-specific inhibitors, we showed that VPS35 loss impairs the translation of SCABR2 and NPC1. Consistently, human iPSC-derived liver organoids lacking VPS35 also exhibited reduced expression of NPC1 and SCARB2 proteins. The decrease in these lysosomal proteins correlated with increased cholesterol levels in the plasma and liver of Vps35HepKO mice. This was likely explained by the disrupted cholesterol trafficking through the endo-lysosomal system, delayed plasma cholesterol turnover, and upregulated cholesterol biosynthesis. ConclusionThese findings uncover a previously unknown role for the hepatic retromer complex in maintaining systemic cholesterol homeostasis. Beyond its established function in endosomal cargo transport, we now demonstrate that retromer is also essential for lysosomal cholesterol handling. This role is mediated by regulating key lysosomal proteins involved in cholesterol metabolism, including LAL, NPC1, and SCARB2.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism
Baley A. Goodson, Valeria F. Montenegro Vazquez, … Jing Pu·Cell ReportsPeer-reviewed·Jun 1, 2026
- Cholesterol-Responsive Interaction of NFE2L1-INSIG1 Controls VLDL Secretion and MASH Pathogenesis
Shijun Deng, Jessica Freed, … Gökhan S. Hotamışlıgil·bioRxiv·Jun 9, 2025
- The ESCRT-0 protein HRS regulates hepatocellular lipid droplet catabolism
Mathilda M. Willoughby, Ankit Shroff, … Micah B. Schott·Molecular Biology of the CellPeer-reviewed·Jun 11, 2026
- VPS13A and VPS13C influence lipid droplet abundance
S. Chen, M. A. Roberts, … S. Ferro-Novick·bioRxiv·Jun 21, 2022
- A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export
D. J. van den Boomen, A. Sienkiewicz, … P. J. Lehner·bioRxiv·Nov 8, 2019
- Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice
D. Moreau, F. Vacca, … J. Gruenberg·bioRxiv·Mar 8, 2019